🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06778785
Active, not recruiting Not applicable

Game-Based Digital Intervention for Depression in Adolescents

NCT06778785 · tracked via the Priya Life Science China tracker
Sponsor
Adai Technology (Beijing) Co., Ltd.
Phase
Not applicable
Started
2024-04-17
Last updated
2025-02-17

Condition(s) studied

DepressionAnxiety

Investigational drug(s) / intervention(s)

Digital InterventionHealth EducationPersonalization Algorithm

Digital Intervention: game-based digital intervention app

Health Education: traditional health education app

Personalization Algorithm: a proprietary algorithm that adaptively adjust the treatment module and parameters to personalize the treatment regime

Study summary

The goal of this clinical trial is to evaluate the effectiveness of digital interventions in treating depression and anxiety in adolescents. The main question it aims to answer is: Can digital interventions effectively alleviate symptoms of depression and anxiety in adolescents? The trial will include a comparison group where researchers will compare the effects of the digital intervention to traditional health education methods to assess their relative efficacy.

Participants will be asked to engage with the digital intervention platform for a period of two months.

Eligibility

Sex
ALL
Min age
10 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * The Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID) will be used to assess participants' eligibility based on the diagnostic criteria for depression outlined in the DSM-5(the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition). * no prior use of antidepressants or antipsychotic medications. * having a HAMD (Hamilton Depression scale) score \>= 8 upon enrollment * demonstrate normal cognitive function. * voluntarily agree to participate in the study, and both they and their legal guardians must provide informed consent. * being able to read and typeset Chinese. Exclusion Criteria: * with severe consciousness disorders and a history of psychiatric illness, traumatic brain injury, substance dependence, or acute poisoning * with concurrent psychiatric disorders (as determined by clinical assessment) * at high risk of suicide

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
West China Hospital Chengdu Sichuang

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06778785 on ClinicalTrials.gov ↗ ← All trials in China